Fig. 2 From: Combined intravitreal dexamethasone and bevacizumab injection for the treatment of persistent diabetic macular edema (DexaBe study): a phase I clinical studyMean logMAR best-corrected visual acuity during the 24-week follow-up period. There was only a trend towards significant improvement at week 1 (p = 0.08)Back to article page